<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04900324</url>
  </required_header>
  <id_info>
    <org_study_id>2020/554</org_study_id>
    <nct_id>NCT04900324</nct_id>
  </id_info>
  <brief_title>Intramuscular Injections of Botulinum Toxin in Lateral Pterygoid Muscle in the Treatment of Temporomandibular Dysfunctions: Studying the Interest of MRI Guidance and Ultrasound Guidance</brief_title>
  <acronym>MAUSBOT</acronym>
  <official_title>Intramuscular Injections of Botulinum Toxin in Lateral Pterygoid Muscle in the Treatment of Temporomandibular Dysfunctions: Studying the Interest of MRI Guidance and Ultrasound Guidance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main hypothesis is that a significant pain improve (measured with Visual Analogic Scale&#xD;
      [VAS]) can be observed after injection of botulinum toxin A, meaning the success of the&#xD;
      guidance device.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2021</start_date>
  <completion_date type="Anticipated">February 2023</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain improvement</measure>
    <time_frame>Month 2</time_frame>
    <description>Significant improvement of the pain measured with VAS (0 to 10), corresponding to at least 30% decrease of the pain after injection of botulinum toxin A</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Mandibular Dysfunction</condition>
  <arm_group>
    <arm_group_label>MRI guidance</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Injections of botulinum toxin performed using MRI guidance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ultrasound guidance</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Injections of botulinum toxin performed using ultrasound guidance</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI guidance</intervention_name>
    <description>Injections of botulinum toxin performed using MRI guidance</description>
    <arm_group_label>MRI guidance</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound guidance</intervention_name>
    <description>Injections of botulinum toxin performed using ultrasound guidance</description>
    <arm_group_label>Ultrasound guidance</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients suffering from muscular TemporoMandibular Dysfunctions (TMD) with clinical&#xD;
             diagnosis: myofascial pain, limited opening of the mouth, articular noise.&#xD;
&#xD;
          -  &gt;= 18 years old&#xD;
&#xD;
          -  with signed informed consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  articular TMD: arthritis or other inflammatory disease of temporomandibular joint,&#xD;
             arthrosis, bone deformation, previous fracture of condylar area ;&#xD;
&#xD;
          -  electromyographic hypoactivity, pure muscular diseases ;&#xD;
&#xD;
          -  oro-mandibular dystonia ;&#xD;
&#xD;
          -  botulinum toxin allergy,&#xD;
&#xD;
          -  risk of bleeding&#xD;
&#xD;
          -  recent or active infection&#xD;
&#xD;
          -  intercurrent antibiotic treatment (drug interaction) ;&#xD;
&#xD;
          -  vaccination during the 15 days preceding the injection.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christophe MEYER, Md PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Besançon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mélanie PONS, Int</last_name>
    <email>mpons@chu-besancon.fr</email>
  </overall_contact>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 19, 2021</study_first_submitted>
  <study_first_submitted_qc>May 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 25, 2021</study_first_posted>
  <last_update_submitted>May 20, 2021</last_update_submitted>
  <last_update_submitted_qc>May 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Temporomandibular Joint Disorders</mesh_term>
    <mesh_term>Temporomandibular Joint Dysfunction Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

